1,126 results on '"Stuschke M"'
Search Results
2. Respiration-controlled radiotherapy in lung cancer: Systematic evaluation of the optimal application practice
3. Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury/remodeling
4. Prospektiv-randomisierte Phase-II-Studie zur Induktionschemotherapie und Radiochemotherapie ± Durvalumab gefolgt von Operation und Durvalumab-Konsolidierung beim resektablen NSCLC III (ESPADURVA): 2021-6 ARO/AIO-TRK-012
5. Stellenwert der adjuvanten externen Strahlentherapie nach Enukleation von Aderhautmelanomen mit extraokularem Wachstum
6. Elektive Strahlentherapie pelviner Lymphknoten beim High-risk-Prostatakarzinom?: Bewertung der Relation zwischen der relativen Risikoreduktion eines PSA-Rezidivs (prostataspezifisches Antigen) innerhalb von 5 Jahren und einem absoluten Überlebensvorteil
7. Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus: mature results of a phase I/II trial
8. Tumorerkrankungen des Kopf-Hals-Bereichs im höheren Lebensalter – aktuelle Aspekte
9. Kuratives Potenzial nichtoperativer Therapiekonzepte beim Adenokarzinom des ösophagogastralen Übergangs
10. Robust Radiosensitization by Combined Treatment of Cancer Cells with Talazoparib and Polθ Inhibitors
11. Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial
12. Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial
13. Targeting ARID1A-mutant colorectal cancer: depletion of ARID1B increases radiosensitivity and modulates DNA damage response
14. MO-0952 A multicentric retrospective analysis of the potential synergy between radiotherapy and CAR T-cells
15. First Clinical Experience with Gallium-68-OPS-202 PET for Imaging SCLC
16. Langzeitergebnisse nach Endoresektion und Gamma-Knife-Bestrahlung großer Aderhautmelanome mit und ohne adjuvanter Brachytherapie
17. DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
18. Retroperitoneale Weichteiltumoren
19. Grundlagen der Radioonkologie
20. Adjuvante Radiotherapie der neovaskulären altersabhängigen Makuladegeneration unter Anti-VEGF
21. MA08.05 Lung Cancer in Young Adults is Associated with Advanced Disease at Diagnosis and Increased Frequency of Targetable Mutations.
22. Impact of whole thorax irradiation on cardiac remodeling and outcome after ischemia/reperfusion
23. EP04.02-007 First Comprehensive Lung Cancer Long-Term Survivorship Program- Competing Risks
24. Prognostic factors after pneumonectomy in lung cancer
25. Präoperatives PET-SUVmax und Volumen-basierte PET Parameter des Primärtumors sind nicht prädiktiv für Upstaging des N-Stadiums im Frühstadium Lungenkrebs
26. EP04.02-005 First Comprehensive Lung Cancer Long-Term Survivorship Program - Late Toxicities and Overall Survival
27. MA06.08 Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLC
28. EP04.01-016 First Comprehensive Lung Cancer Long-Term Survivorship Analysis - Late Toxicities and Overall Survival
29. EP05.01-030 CRISP: First Real-World Evidence of NSCLC Stage I, II and III in Germany - AIO-TRK-0315
30. P17.04.B Combination of Trofosfamide and Etoposide in Recurrent Glioma
31. 963P Clinical research platform Into molecular testing, treatment and outcome of non-Small cell lung carcinoma Patients (CRISP): Real-world evidence of NSCLC patients treated with radiochemotherapy in Germany – AIO-TRK-0315
32. OS06.5.A Investigating safety and efficacy of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma - the PriCoTTF phase I/II trial
33. EP02.01-010 Preoperative PET-SUVmax and Volume Based PET Metrics of the Tumor Fail to Predict Nodal Upstaging in Early-Stage Lung Cancer
34. Clinical Research platform Into molecular testing, treatment and outcome of non-Small cell lung carcinoma Patients (CRISP): Real-World Evidence of NSCLC Stage I, II and III in Germany – AIO-TRK-0315
35. 671P Postoperative chemoradiation in combination with cetuximab followed by 6-months cetuximab maintenance in squamous cell carcinoma of the head and neck with high risk of locoregional recurrence
36. P11.15.B First multicentric real-life experience with the combination of lomustine and temozolomide in newly diagnosedMGMT promoter methylatedIDH wildtype glioblastoma
37. EP.07D.10 Deciphering Destiny: Is Curation of NSCLC Limited to Stage IA?
38. EP.07A.19 Impact of Preoperative Pulmonary Function on Survival Following Lobectomy for Stage I and II Lung Cancer
39. P1.06C.05 The Impact of Lymphovascular Invasion as Prognostic Factor on Long-Term Survival in More Than 3500 Resected NSCLC Patients
40. Retroperitoneale Weichteiltumoren
41. Grundlagen der Radioonkologie
42. Retroperitoneale Weichteiltumoren
43. Grundlagen der Radioonkologie
44. Cholangiozelluläres Karzinom
45. Kleinzelliges Lungenkarzinom
46. Schilddrüsenkarzinom
47. Neue Strahlenarten — Strahlentherapie mit schweren Teilchen
48. Die neue S3-Leitlinie zum Ösophaguskarzinom: Wichtige chirurgische Aspekte
49. Strahlentherapie beim Ösophaguskarzinom
50. Role of Growth Factors and Biological Response Modifiers in Lung, Head and Neck and Gastrointestinal Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.